Intravitreal Bevacizumab vs. Bevacizumab Combined With Triamcinolone for Neovascular AMD

Sponsor
Shahid Beheshti University of Medical Sciences
Study ID
NCT00370370
Phase
PHASE3
Status
Unknown

Conditions

  • Neovascular Age-Related Macular Degeneration

Eligibility Criteria

Sex
ALL
Age
50 Years - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

To compare the efficacy and safety results of intravitreal bevacizumab alone with bevacizumab + triamcinolone acetonide in neovascular AMD.

Key Dates

First listed
Aug 31, 2006
Start date
Nov 30, 2005
Status verified
Jun 2008

Study Design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Active Comparator: 1
    Injection of intravitreal bevacizumab
  • Active Comparator: 2
    Injection of bevacizumab + triamcinolone acetonide

Primary Outcome Measure

visual acuity

Related Studies